AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday. "Following discussions with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback